CANCER THERAPY

• 收藏
• 分享

专利权人:

UCL BUSINESS PLC

发明人:

Jasper DE BOER,Sandra CANTILENA

申请号：

US16344757

公开号：

US20190274976A1

申请日:

2017.11.02

申请国别(地区):

US

年份:

2019

代理人:

摘要：

The present invention relates to the treatment of mixed lineage leukemia. In particular, the present invention relates to therapies involving the induction of proteolysis of the MLL fusion proteins that result from the chromosomal translocations affecting the MLL gene at 11q23.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/